Abstract
Defensins, a family of antimicrobial peptides, are one of the first lines of host defense. Human beta-defensins (hBD) such as hBD-2 and -3 have anti-HIV activity. Previous studies have shown that HIV-1 virion can induce the expression of hBD, although the exact components of HIV-1 virion that are responsible for hBD expression have not yet been elucidated. In this study, we examined the effect of HIV-1 Tat on the expression of hBD in B cells. Stimulation of B cells with HIV-1 Tat protein significantly increased the mRNA and protein levels of hBD-2. HIV-1 Tat also induced the activation of a reporter gene for hBD-2 in a dose-dependent manner in B cells. Pretreatment of B cells with a JNK inhibitor suppressed HIV-1 Tat-induced hBD-2 expression. Pretreatment of B cells with AP-1 inhibitors or NF-κB inhibitors led to a decrease in HIV-1 Tat-induced protein and mRNA expression of hBD-2. Taken together, our results indicate that HIV-1 Tat can up-regulate the expression of hBD-2 via JNK-NF-κB/AP-1-dependent pathways in human B cells.
Similar content being viewed by others
References
Bowdish, D.M., Davidson, D.J., and Hancock, R.E. (2006). Immunomodulatory properties of defensins and cathelicidins. Curr. Top Microbiol. Immunol. 306, 27–66.
Chang, T.L., Vargas, J.Jr., DelPortillo, A., and Klotman, M.E. (2005). Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity. J. Clin. Invest. 115, 765–773.
Cole, A.M., and Lehrer, R.I. (2003). Minidefensins: antimicrobial peptides with activity against HIV-1. Curr. Pharm. Des. 9, 1463–1473.
Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V., Gendelman, R., Morgan, R.A., Wingfield, P., and Gallo, R.C. (1993). Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67, 277–287.
Furci, L., Sironi, F., Tolazzi, M., Vassena, L., and Lusso, P. (2007). Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4. Blood 109, 2928–2935.
Gallo, S.A., Wang, W., Rawat, S.S., Jung, G., Waring, A.J., Cole, A.M., Lu, H., Yan, X., Daly, N.L., Craik, D.J., et al. (2006). Thetadefensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation. J. Biol. Chem. 281, 18787–18792.
Greene, W.C., Debyser, Z., Ikeda, Y., Freed, E.O., Stephens, E., Yonemoto, W., Buckheit, R.W., Esté, J.A., and Cihlar, T. (2008). Novel targets for HIV therapy. Antiviral Res. 80, 251–265.
Han, S.H., Kim, Y.E., Park, J.A., Park, J.B., Kim, Y.S., Lee, Y., Choi, I.G., and Kwon, H.J. (2009). Expression of human beta-defensin-2 gene induced by CpG-DNA in human B cells. Biochem. Biophys. Res. Commun. 389, 443–448.
Herbein, G., Gras, G., Khan, K.A., and Abbas, W. (2010). Macrophage signaling in HIV-1 infection. Retrovirology 7, 34.
Hrecka, K., Hao, C., Gierszewska, M., Swanson, S.K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M.P., and Skowronski, J. (2011). Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474, 658–661.
Huang, L., Li, C.J., and Pardee, A.B. (1997). Human immunodeficiency virus type 1 TAT protein activates B lymphocytes. Biochem. Biophys. Res. Commun. 237, 461–464.
Huigen, M.C., Kamp, W., and Nottet, H.S. (2004). Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection. Eur. J. Clin. Invest. 34, 57–66.
Jang, B.C., Lim, K.J., Paik, J.H., Kwon, Y.K., Shin, S.W., Kim, S.C., Jung, T.Y., Kwon, T.K., Cho, J.W., Baek, W.K., et al. (2004). Upregulation of human beta-defensin 2 by interleukin-1beta in A549 cells: involvement of PI3K, PKC, p38 MAPK, JNK, and NF-kappaB. Biochem. Biophys. Res. Commun. 320, 1026–1033.
Ju, S.M., Song, H.Y., Lee, J.A., Lee, S.J., Choi, S.Y., and Park, J. (2009). Extracellular HIV-1 Tat up-regulates expression of matrix metalloproteinase-9 via a MAPK-NF-kappaB dependent pathway in human astrocytes. Exp. Mol. Med. 41, 86–93.
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., and Benkirane, M. (2011). SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654–657.
Lehrer, R.I., and Ganz, T. (2002). Defensins of vertebrate animals. Curr. Opin. Immunol. 14, 96–102.
Lee, J.A., Song, H.Y., Ju, S.M., Lee, S.J., Seo, W.Y., Sin, D.H., Goh, A.R., Choi, S.Y., and Park, J. (2010). Suppression of inducible nitric oxide synthase and cyclooxygenase-2 by cell-permeable superoxide dismutase in lipopolysaccharide-stimulated BV-2 microglial cells. Mol. Cells 29, 245–250.
Lever, R.A., and Lever, A.M. (2011). Intracellular defenses against HIV, viral evasion and novel therapeutic approaches. J. Formos. Med. Assoc. 110, 350–362.
Martin-Serrano, J., and Neil, S.J. (2011). Host factors involved in retroviral budding and release. Nat. Rev. Microbiol. 9, 519–531.
Méndez-Samperio, P., Alba, L., and Trejo, A. (2007) Mycobacterium bovis-mediated induction of human beta-defensin-2 in epithelial cells is controlled by intracellular calcium and p38-MAPK. J. Infect. 54, 469–474.
Pu, H., Tian, J., Flora, G., Lee, Y.W., Nath, A., Hennig, B., and Toborek, M. (2003) HIV-1 Tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain. Mol. Cell. Neurosci. 24, 224–237.
Quñones-Mateu, M.E., Lederman, M.M., Feng, Z., Chakraborty, B., Weber, J., Rangel, H.R., Marotta, M.L., Mirza, M., Jiang, B., Kiser, P., et al. (2003). Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS 17, F39–48.
Rahman, A., Fahlgren, A., Sitohy, B., Baranov, V., Zirakzadeh, A., Hammarström, S., Danielsson, A., and Hammarström, M.L. (2007). Beta-defensin production by human colonic plasma cells: a new look at plasma cells in ulcerative colitis. Inflamm. Bowel Dis. 13, 847–855.
Rapista, A., Ding, J., Benito, B., Lo, Y.T., Neiditch, M.B., Lu, W., and Chang, T.L. (2011). Human defensins 5 and 6 enhance HIV-1 infectivity through promoting HIV attachment. Retrovirology 8, 45.
Sheehy, A.M., Gaddis, N.C., Choi, J.D., and Malim, M.H. (2002). Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646–650.
Shin, J.E., and Choi, Y. (2010). Treponema denticola suppresses expression of human beta-defensin-2 in gingival epithelial cells through inhibition of TNFalpha production and TLR2 activation. Mol. Cells 29, 407–412.
Song, H.Y., Ju, S.M., Seo, W.Y., Goh, A.R., Lee, J.K., Bae, Y.S., Choi, S.Y., and Park, J. (2011). Nox2-based NADPH oxidase mediates HIV-1 Tat-induced up-regulation of VCAM-1/ICAM-1 and subsequent monocyte adhesion in human astrocytes. Free Radic. Biol. Med. 50, 576–584.
Stremlau, M., Owens, C.M., Perron, M.J., Kiessling, M., Autissier, P., and Sodroski, J. (2004). The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427, 848–853.
Sun, L., Finnegan, C.M., Kish-Catalone, T., Blumenthal, R., Garzino-Demo, P., La Terra Maggiore, G.M., Berrone, S., Kleinman, C., Wu, Z., Abdelwahab, S., et al. (2005) Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J. Virol. 79, 14318–14329.
Tsutsumi-Ishii, Y., and Nagaoka, I. (2002). NF-kappaB-mediated transcriptional regulation of human beta-defensin-2 gene following lipopolysaccharide stimulation. J. Leukoc. Biol. 71, 154–162.
Wehkamp, K., Schwichtenberg, L., Schröder, J.M., and Harder, J. (2006). Pseudomonas aeruginosa- and IL-1beta-mediated in duction of human beta-defensin-2 in keratinocytes is controlled by NF-kappaB and AP-1. J. Invest. Dermatol. 126, 121–127.
Weinberg, A., Quiñones-Mateu, M.E., and Lederman, M.M. (2006). Role of human beta-defensins in HIV infection. Adv. Dent. Res. 19, 42–48.
Yoon, Y.M., Lee, J.Y., Yoo, D., Sim, Y.S., Kim, Y.J., Oh, Y.K., Kang, J.S., Kim, S., Kim, J.S., and Kim, J.M. (2010). Bacteroides fragilis enterotoxin induces human beta-defensin-2 expression in in-testinal epithelial cells via a mitogen-activated protein kinase/I kappaB kinase/NF-kappaB-dependent pathway. Infect. Immun. 78, 2024–2033.
Zapata, W., Rodriguez, B., Weber, J., Estrada, H., Quñones-Mateu, M.E., Zimermman, P.A., Lederman, M.M., and Rugeles, M.T. (2008). Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals. Curr. HIV Res. 6, 531–538.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ju, S.M., Goh, A.R., Kwon, DJ. et al. Extracellular HIV-1 Tat induces human beta-defensin-2 production via NF-kappaB/AP-1 dependent pathways in human B cells. Mol Cells 33, 335–341 (2012). https://doi.org/10.1007/s10059-012-2287-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10059-012-2287-0